Funded by
the European Union
🌟 EuCARE Surpasses 50,000 Patient Milestone! The EuCARE initiative has reached a significant milestone, enrolling over 50,000 patients across its clinical cohorts. These cohorts include
EuCARE partners made contributions to the Conference on Retroviruses and Opportunistic Infections 2024 (CROI), held from March 3rd to 6th, 2024. This prestigious conference, established
On January 30, the first meeting of the Coordination Board, a COMECT (Coordination Mechanism for Cohorts and Trials) activity, was held, gathering together the Cohort
This cohort study within the EuCARE project entitled: “In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the
How do SARS-COV-2 variants, coupled with other factors, influence the short- and long-term clinical course of COVID-19? Is the efficacy of vaccines or diagnostic tests affected as new variants emerge? Does treatment efficacy vary among variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
34 institutions from 4 continents collaborate to find answers to these and other crucial questions and to create a sustainable network to promptly tackle similar issues in the future.
FUNDED BY THE EC UNDER HORIZON-HLTH-2021-CORONA-01
- GRANT AGREEMENT NO 101046016
Get to know the project and its scope
Find out all the media news about the EuCARE Project.
